CCOP-Colorado Cancer Research Prog. Inc.(Administrative Only) — Denver, Colorado

CCOP-Colorado Cancer Research Prog. Inc.(Administrative Only) is a clinical research site located in Denver, Colorado, United States 80224.

Crixeo Clinical Trials Trust Score: 6/100 (FAILING). This profile has not yet been claimed by the site owner.

CCOP-Colorado Cancer Research Prog. Inc.(Administrative Only) has participated in 2 clinical trials.

Therapeutic areas: Breast Cancer, Invasive Breast Cancer.

Sponsors: NSABP Foundation Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Denver

Browse all research sites in Colorado · View every site in Denver

Sponsor Feasibility Report

Trust Score: 6/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CCOP-Colorado Cancer Research Prog. Inc.(Administrative Only)?

CCOP-Colorado Cancer Research Prog. Inc.(Administrative Only) has a Crixeo Trust Score of 6/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CCOP-Colorado Cancer Research Prog. Inc.(Administrative Only) conducted?

CCOP-Colorado Cancer Research Prog. Inc.(Administrative Only) has 2 clinical trials on record. Their work covers Breast Cancer, Invasive Breast Cancer.

Is CCOP-Colorado Cancer Research Prog. Inc.(Administrative Only) accredited by Crixeo Clinical Trials?

CCOP-Colorado Cancer Research Prog. Inc.(Administrative Only) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CCOP-Colorado Cancer Research Prog. Inc.(Administrative Only)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.